华人健康
(301408)
| 流通市值：18.68亿 | | | 总市值：50.08亿 |
| 流通股本：1.49亿 | | | 总股本：4.00亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,266,605,691.51 | 1,336,326,502.97 | 1,195,782,303.48 | 1,133,328,550.9 |
| 结算备付金 | 0 | 0 | 0 | - |
| 拆出资金 | 0 | 0 | 0 | - |
| 衍生金融资产 | 0 | 0 | 0 | - |
| 应收票据及应收账款 | 565,537,472.5 | 493,542,322.21 | 504,100,774.21 | 438,998,144.94 |
| 其中：应收票据 | 0 | 0 | 8,582,654.51 | - |
| 应收账款 | 565,537,472.5 | 493,542,322.21 | 495,518,119.7 | 438,998,144.94 |
| 应收款项融资 | 9,844,044.68 | 19,601,193.75 | 7,296,716.08 | 5,272,148.04 |
| 预付款项 | 121,391,737.09 | 137,321,625.28 | 153,880,242.12 | 144,795,739.89 |
| 应收保费 | 0 | 0 | 0 | - |
| 应收分保账款 | 0 | 0 | 0 | - |
| 应收分保合同准备金 | 0 | 0 | 0 | - |
| 其他应收款合计 | 59,255,708.31 | 36,236,200.82 | 55,195,095.32 | 44,083,195.97 |
| 其中:应收利息 | 0 | 0 | 0 | - |
| 应收股利 | 0 | 0 | 0 | - |
| 买入返售金融资产 | 0 | 0 | 0 | - |
| 存货 | 911,360,890.33 | 772,087,871.23 | 787,647,498.04 | 751,158,760.43 |
| 合同资产 | 0 | 0 | 0 | - |
| 一年内到期的非流动资产 | 0 | 0 | 0 | - |
| 其他流动资产 | 22,093,036.44 | 18,733,210.79 | 13,857,283.68 | 16,103,270.21 |
| 流动资产其他项目 | 0 | 0 | - | - |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 2,963,808,764.97 | 2,826,254,957.65 | 2,738,682,387.1 | 2,535,742,953.49 |
| 非流动资产: | | | | |
| 发放委托贷款及垫款 | - | 0 | - | - |
| 债权投资 | 0 | 0 | 0 | - |
| 其他债权投资 | 0 | 0 | 0 | - |
| 长期应收款 | 0 | 0 | 0 | - |
| 长期股权投资 | 14,428,257.15 | 14,428,257.15 | 0 | - |
| 其他权益工具投资 | 82,879,209.82 | 78,379,209.82 | 76,530,969 | 81,127,900.28 |
| 其他非流动金融资产 | 0 | 0 | 0 | - |
| 投资性房地产 | 1,913,211.03 | 1,929,147.24 | 0 | - |
| 固定资产 | 333,334,307.55 | 330,258,514.21 | 180,126,227.83 | 58,223,590.26 |
| 在建工程 | 102,844,607.12 | 61,335,843.94 | 130,482,913.35 | 90,155,023.75 |
| 生产性生物资产 | 0 | 0 | 0 | - |
| 油气资产 | 0 | 0 | 0 | - |
| 使用权资产 | 473,175,768.53 | 478,551,565.2 | 486,785,953.13 | 471,628,219.92 |
| 无形资产 | 66,522,932.43 | 62,506,565.09 | 63,471,062.34 | 32,262,902.59 |
| 开发支出 | 0 | 0 | 0 | - |
| 商誉 | 769,168,633.52 | 609,312,977.19 | 602,717,608.34 | 457,163,601.81 |
| 长期待摊费用 | 56,207,063.29 | 52,106,611.6 | 50,799,231.52 | 50,656,016.89 |
| 递延所得税资产 | 40,226,234.42 | 32,827,464.23 | 29,411,313.28 | 24,799,860.39 |
| 其他非流动资产 | 33,354,100 | 63,806,806.33 | 68,472,197.58 | 47,016,085.12 |
| 非流动资产其他项目 | 0 | 0 | - | - |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,974,054,324.86 | 1,785,442,962 | 1,688,797,476.37 | 1,313,033,201.01 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 4,937,863,089.83 | 4,611,697,919.65 | 4,427,479,863.47 | 3,848,776,154.5 |
| 流动负债: | | | | |
| 短期借款 | 312,740,945.28 | 513,512,092.5 | 216,401,611.11 | 241,401,611.11 |
| 向中央银行借款 | 0 | 0 | 0 | - |
| 吸收存款及同业存放 | 0 | 0 | 0 | - |
| 拆入资金 | 0 | 0 | 0 | - |
| 交易性金融负债 | 0 | 0 | 0 | - |
| 衍生金融负债 | 0 | 0 | 0 | - |
| 应付票据及应付账款 | 1,349,000,497.01 | 1,026,818,003.38 | 1,252,814,536.2 | 913,364,188.56 |
| 其中：应付票据 | 834,510,548.19 | 773,930,812.61 | 766,898,957.06 | 536,467,354.54 |
| 应付账款 | 514,489,948.82 | 252,887,190.77 | 485,915,579.14 | 376,896,834.02 |
| 预收款项 | 4,954,981.14 | 5,733,761.78 | 4,382,827.73 | 4,066,278.94 |
| 合同负债 | 39,211,528.01 | 21,329,077.31 | 23,887,828.07 | 16,290,213.9 |
| 卖出回购金融资产款 | 0 | 0 | 0 | - |
| 应付手续费及佣金 | 0 | 0 | 0 | - |
| 应付职工薪酬 | 45,717,962.61 | 43,861,712.56 | 41,441,598.29 | 37,109,788.8 |
| 应交税费 | 35,770,710.04 | 23,952,142.82 | 20,302,413.7 | 18,827,697.49 |
| 其他应付款合计 | 104,828,338.65 | 70,572,909.07 | 86,385,886.69 | 128,936,606.15 |
| 其中:应付利息 | 0 | 0 | 0 | - |
| 应付股利 | 0 | 0 | 0 | - |
| 应付分保账款 | 0 | 0 | 0 | - |
| 保险合同准备金 | 0 | 0 | 0 | - |
| 代理买卖证券款 | 0 | 0 | 0 | - |
| 代理承销证券款 | 0 | 0 | 0 | - |
| 一年内到期的非流动负债 | 249,554,799.12 | 255,389,025.24 | 180,025,912.75 | 172,412,816.72 |
| 其他流动负债 | 4,207,833.22 | 2,566,484.99 | 2,137,606.65 | 1,706,584.16 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 2,145,987,595.08 | 1,963,735,209.65 | 1,827,780,221.19 | 1,534,115,785.83 |
| 非流动负债: | | | | |
| 长期借款 | 431,209,518.32 | 331,152,444.44 | 237,580,335.28 | 145,640,155.97 |
| 应付债券 | 0 | 0 | 0 | - |
| 优先股 | 0 | 0 | 0 | - |
| 永续债 | 0 | 0 | 0 | - |
| 租赁负债 | 223,144,419.5 | 237,650,528.14 | 260,038,318.04 | 252,169,834.84 |
| 长期应付款 | 94,154,488.5 | 95,400,000 | 146,900,000 | - |
| 长期应付职工薪酬 | 0 | 0 | 0 | - |
| 预计负债 | 0 | 0 | 0 | - |
| 递延收益 | 908,073.29 | 908,073.29 | 908,073.29 | - |
| 递延所得税负债 | 7,179,044.63 | 6,321,546.84 | 6,793,715.15 | - |
| 其他非流动负债 | 0 | 0 | 0 | - |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 756,595,544.24 | 671,432,592.71 | 652,220,441.76 | 397,809,990.81 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 2,902,583,139.32 | 2,635,167,802.36 | 2,480,000,662.95 | 1,931,925,776.64 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 400,010,000 | 400,010,000 | 400,010,000 | 400,010,000 |
| 其他权益工具 | 0 | 0 | 0 | - |
| 优先股 | 0 | 0 | 0 | - |
| 永续债 | 0 | 0 | 0 | - |
| 资本公积 | 1,014,137,343.23 | 1,014,137,343.23 | 1,014,137,343.23 | 1,014,137,343.23 |
| 减:库存股 | 0 | 0 | 0 | - |
| 其他综合收益 | 0 | 0 | 0 | - |
| 专项储备 | 0 | 0 | 0 | - |
| 盈余公积 | 31,300,292.76 | 31,300,292.76 | 26,272,505.56 | 26,059,027 |
| 一般风险准备 | 0 | 0 | 0 | - |
| 未分配利润 | 545,857,792.09 | 498,085,491.05 | 476,462,992.35 | 446,901,785.61 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,991,305,428.08 | 1,943,533,127.04 | 1,916,882,841.14 | 1,887,108,155.84 |
| 少数股东权益 | 43,974,522.43 | 32,996,990.25 | 30,596,359.38 | 29,742,222.02 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 2,035,279,950.51 | 1,976,530,117.29 | 1,947,479,200.52 | 1,916,850,377.86 |
| 负债和股东权益合计 | 4,937,863,089.83 | 4,611,697,919.65 | 4,427,479,863.47 | 3,848,776,154.5 |
| 公告日期 | 2024-04-29 | 2024-04-29 | 2023-10-28 | 2023-08-25 |
| 审计意见(境内) | | 标准无保留意见 | | |